Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ocugen

0.7369
+0.01992.78%
Volume:2.11M
Turnover:1.54M
Market Cap:215.19M
PE:-3.69
High:0.7400
Open:0.7152
Low:0.7100
Close:0.7170
Loading ...

Ocugen Inc - No Serious Adverse Events Reported for Ocu410

THOMSON REUTERS
·
19 Dec 2024

Ocugen Inc: Ocu410 Has a Very Favorable Safety and Tolerability Profile

THOMSON REUTERS
·
19 Dec 2024

Data and Safety Monitoring Board Reviews Interim Safety Data of Phase 2 Subjects of Ocu410 Armada Clinical Trial for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration

THOMSON REUTERS
·
19 Dec 2024

Data and Safety Monitoring Board Reviews Interim Safety Data of Phase 2 Subjects of OCU410 ArMaDa Clinical Trial for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration

GlobeNewswire
·
19 Dec 2024

Ocugen Inc. Stock Falls Wednesday, Underperforms Market

Dow Jones
·
19 Dec 2024

Ocugen Inc. Stock Falls Monday, Underperforms Market

Dow Jones
·
17 Dec 2024

Ocugen Inc. Stock Rises Friday, Outperforms Market

Dow Jones
·
14 Dec 2024

Ocugen Inc. Stock Falls Wednesday, Underperforms Market

Dow Jones
·
12 Dec 2024

Ocugen CEO to Present at Oppenheimer Movers in Rare Disease Summit

GlobeNewswire
·
11 Dec 2024

Ocugen Inc. Stock Rises Monday, Outperforms Market

Dow Jones
·
10 Dec 2024

Ocugen Inc. Stock Falls Thursday, Underperforms Market

Dow Jones
·
06 Dec 2024

Ocugen Inc. Stock Falls Tuesday, Underperforms Market

Dow Jones
·
04 Dec 2024

Ocugen Inc. Stock Falls Monday, Underperforms Market

Dow Jones
·
03 Dec 2024

Ocugen Inc. Stock Rises Friday, Outperforms Market

Dow Jones
·
30 Nov 2024

Ocugen Inc. Stock Rises Wednesday, Outperforms Market

Dow Jones
·
28 Nov 2024

Ocugen CEO to Present at NobleCon20 – Noble Capital Markets’ 20th Annual Emerging Growth Equity Conference

GlobeNewswire
·
27 Nov 2024

Ocugen Inc. Stock Rises Monday, Outperforms Market

Dow Jones
·
26 Nov 2024

Ocugen Inc. Stock Rises Friday, Outperforms Market

Dow Jones
·
23 Nov 2024

Ocugen Inc. Stock Rises Wednesday, Outperforms Market

Dow Jones
·
21 Nov 2024

Ocugen's Eye Disease Treatment Receives Orphan Drug Designation in Europe for Retinopathies

MT Newswires Live
·
20 Nov 2024